Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants
Clinical trial NCT05338502 · COMPLETED
Trial details
- NCT number
- NCT05338502
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2019-09-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.